Dr. Mothaffar F. Rimawi M.D.
Hematologist-Oncologist | Hematology & Oncology
6620 Main St Breast Center, Suite Houston TX, 77030Rating
4/5
About
Dr. Mothaffar Rimawi is a hematologist oncologist practicing in Houston, TX. Dr. Rimawi specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Faculty of Medicine (Amman, Jordan) MD 1997
University of Jordan Faculty of Medicine 1997
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.
- High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
- β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
- Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.
- Breast Cancer: Blocking both driver and escape pathways improves outcomes.
- Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
- Predictors of post-mastectomy reconstruction in an underserved population.
- Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.
- Aromatase inhibitor adverse effects: are we sweeping them under the rug?
- Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
- A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer.
- Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
- Targeting HER2 for the treatment of breast cancer.
- Resistance to Anti-HER2 Therapies in Breast Cancer.
- Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.
Clinical Trials
- Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
- Ruxolitinib for Premalignant Breast Disease
- Phase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
- Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
- High Dose Vitamin D vs Standard Dose Vitamin D Study
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- NSABP Biospecimen Discovery Project
Treatments
- Breast Cancer, Brain Tumor, Breast Biopsy
- Breast Cancer
Dr. Mothaffar F. Rimawi M.D.'s Practice location
Mothaffar Rimawi
6620 Main St Breast Center, Suite -Houston, TX 77030Get Direction
Dr. Mothaffar F. Rimawi M.D.'s reviews
Write ReviewPatient Experience with Dr. Rimawi
Recommended Articles
- Tips on How to Live with Multiple Myeloma
Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...
![]()
A Triathlon for BloodwiseWhere would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...
![]()
Teen Finds Strength to Give Back After Battling LymphomaAyden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...
![]()
Boy Who Donated Hair to Kids with Cancer Fights Stage Four LymphomaTorrin Breneman first learned about cancer three years ago, and it made an impact on him. When he learned what cancer can do to a person, and that it affects children across the world, Torrin made a decision to do something about it. He grew out his hair for the next three years, with the intentions...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
![]()
Mr. T's Lessons on Life and LymphomaThere are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...
Nearby Providers
![]()
Mr. Amir Rasheed M.D.13111 E Freeway Houston TX 77015![]()
Dr. Mohamed Haq MD11950 Old Galveston Rd Houston TX 77034![]()
Dr. Charles L Conlon MD16675 Southwest Fwy Sugar Land TX 77479![]()
Dr. Jorge German Darcourt M.D.16675 Southwest Fwy Sugar Land TX 77479![]()
Dr. Sahba Q Nadeem MD11914 Astoria Blvd Houston TX 77089![]()
Dr. George T Conklin M.D.1200 Binz St Houston TX 77004
Nearest Hospitals
TEXAS CHILDRENS HOSPl
6621 FANNIN STREET HOUSTON TX 77030CHI ST LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEl
6720 BERTNER HOUSTON TX 77030METHODIST HOSPITAL,THEl
6565 FANNIN HOUSTON TX 77030